Organized in collaboration with the Croucher Foundation and The University of Hong Kong

Summary of Meeting:Emerging and re-emerging viruses have the potential to cause high morbidity and mortality and range from localized outbreaks to epidemics. Due to their emerging nature, most aspects of the biology and infectious potential of these viruses are poorly understood. Our continuing struggle to respond to a procession of pandemics including SARS, avian influenza, MERS, Ebola and more recently Zika, highlights key gaps in our knowledge and should serve to motivate our re-thinking on how we can better prepare and deal with future unknown viral threats. This meeting will focus on important areas such as surveillance, diagnostics and countermeasures and other important advances in new technologies and how they are being applied to research. Furthermore, we will discuss how to facilitate the translation of research, data and candidate treatments through the development pipeline in a timely and cost-effective manner. The key themes to be covered include the need to understand why zoonotic diseases matter, their association with agriculture, the importance of surveillance and early detection, and the difficulties of dealing with diseases that involve both medical and veterinary communities. The conference will bring together experts in virology, immunology, vaccinology, epidemiology with those that seek to transfer knowledge between these groups, veterinarians and industry and government.
Further, this meeting would bring together individuals involved in the control of these diseases in government and non-government organizations, as well as people involved in study of zoonosis and countermeasures. The creation of global networks and sharing of information will ensure that we are better prepared for future outbreaks.

The meeting will begin on Sunday, October 14 with
registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00.
Conference events conclude on Thursday, October 18 with a
closing plenary session from 13:30 to 18:30,
followed by dinner. We recommend return travel
on Friday, October 19 in order to fully experience the meeting.

SUNDAY, OCTOBER 14

16:00—20:00

Arrival and Registration

Hotel Jen Lobby

18:00—20:00

Welcome Mixer

No registration fees are used to fund alcohol served at this function.

Mauro Martins Teixeira,
Universidade Federal de Minas Gerais, Brazil
The Role of Glutamate Receptors in the Pathogenesis of Zika

Natalie A. Prow,
University of South Australia, Australia
A New Replication-Defective, Vaccinia-Derived, CHO-Manufactured Vaccine Vector System (SCV) Is Effective in
Preclinical Studies against Zika and Chikungunya Viruses

Adam Joseph Hume,
Boston University, USA
Short Talk: The Use of Minigenome Systems as Tools to “Fill in the Blanks” for Uncultured Emerging Viruses and Facilitate
Virus Rescue: A Lloviu Virus Case Study

Ralph S. Baric,
University of North Carolina at Chapel Hill, USA
Rapid Response Strategies to Control Emerging Coronavirus Infections

Dong-Yan Jin,
University of Hong Kong, Hong Kong
Short Talk: Suppression of Type I Interferon Production by Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein through Interaction with HSP70 Chaperone

Lisa E. Gralinski,
University of North Carolina, USA
Short Talk: Using a Reduced Complexity Cross to Identify Host Susceptibility Factors to SARS-CoV Infection

Coffee Break

*
Bart L. Haagmans,
Erasmus MC, Netherlands

John W. Lowenthal,
Deakin University, Australia
A Strategy for Developing a MERS Camel Vaccine in Order to Protect Humans

Kenrie Pui Yan Hui,
University of Hong Kong, Hong Kong
Short Talk: Tropism and Pathogenesis of the Avian Influenza A/H7N9 Virus in ex vivo and in vitro Cultures of the Human Respiratory Tract and Human Airway Organoids

We gratefully acknowledge the generous grant for this conference provided by:

Funding for this conference was made possible (in part) by 1 R13 AI140574-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Takeda Pharmaceutical Company Limited

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

If your organization is interested in joining these entities in support of Keystone
Symposia, please contact:&nbspSarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org,Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.